UROGENITAL NEOPLASMS
Clinical trials for UROGENITAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UROGENITAL NEOPLASMS trials appear
Sign up with your email to follow new studies for UROGENITAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Kidney cancer combo trial halted early – what we know
Disease control TerminatedThis study tested a new drug (NKT2152) combined with two other medicines (palbociclib and sasanlimab) in people with advanced clear cell kidney cancer that had worsened after prior treatments. The goal was to see if the combination was safe and could shrink tumors. The trial was …
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE2 • Sponsor: NiKang Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Skin-Saving paste for cancer radiation falls short in tiny trial
Prevention TerminatedThis study tested whether Alkagin paste could prevent skin damage in patients receiving radiation for anal, rectal, or gynecological cancers. Only 2 people enrolled before the trial was stopped early. Because of this, we cannot draw any reliable conclusions about the paste's effe…
Matched conditions: UROGENITAL NEOPLASMS
Phase: PHASE2 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC